Thoma Bravo’s Proofpoint Agrees to Buy Varonis for $6.3 Billion
Shareholders get $49.75 per share, a 52% premium to the June 22 price.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
Shareholders get $49.75 per share, a 52% premium to the June 22 price.
Semtech stock fell sharply following its Analyst Day as the company’s long-term $3.2 billion revenue goal failed to satisfy the market’s elevated expectations.
Shares of CrowdStrike, Palo Alto, and other cyber firms declined after Perplexity made its SPACE AI containment tool free and open source.
Credit markets pressure CoreWeave on financing risks. Nvidia’s Huang rejects a rescue while Bank of America raises revenue forecasts.
Lone Star and Atlas Holdings are exploring bids for International Paper’s European packaging business, potentially valued under $6bn, threatening its planned London float.
Analysts see sustained sales growth from better pricing and a November 3 update.